Hidehito Horinouchi

58PUBLICATIONS
263CO-AUTHORS
Molecular targetsLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (58)

|Sep 22, 2026
Comprehensive Genomic Profiling Beyond Driver Testing in Non-Squamous Non-Small Cell Lung Cancer With Known Drivers.

|Aug 17, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.3.

|Jul 27, 2026
SKYSCRAPER-01: Tiragolumab in Combination With Atezolizumab in Previously Untreated PD-L1-High, Locally Advanced, Unresectable or Metastatic Non-Small Cell Lung Cancer.

|Jun 02, 2026
Role of VEGFA/VEGFR2 signaling in predicting clinical outcomes of EGFR-TKI treatment in EGFR-mutant non-small cell lung cancer.

|May 26, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.1.

|Feb 11, 2026
Immune checkpoint inhibitors in nuclear protein in testis carcinoma treatment: evidence of limited clinical benefits from a case series.

Tomoaki Nakamura, Tatsuya Yoshida, Akihiko Yoshida

Pageof 10

Frequent Collaborators

13 joint publications

Yuichiro Ohe

11 joint publications

Tatsuya Yoshida

9 joint publications

Yusuke Okuma

7 joint publications

Kouya Shiraishi